Molecular Characterization of TFE3 rearranged Renal Cell Carcinoma: A Study of Twenty-one Cases

被引：0
|
作者：
Wei, Shuanzeng [1 ]
Krause, Harris [2 ]
Geynisman, Daniel [1 ]
Elliott, Andrew [2 ]
Yin, Jun [3 ]
Barata, Pedro [4 ]
Heath, Elisabeth [5 ]
Farrell, Alex [3 ]
Nabhan, Chadi [3 ]
Ali-Fehmi, Rouba [6 ]
Mckay, Rana [7 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Caris Life Sci, Irving, TX USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Tulane Med Sch, New Orleans, LA USA
[5] Karmanos Canc Inst, Detroit, MD USA
[6] Wayne State Univ, Detroit, MI USA
[7] UC San Diego Hlth, La Jolla, CA USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
833
引用
收藏
页码：S824 / S824
页数：1
相关论文
共 50 条
  • [31] Characterization of chimeric TFE3 transcription factors found in Xp11.2 translocation renal cell carcinoma
    Motoshima, Takanobu
    Hasumi, Hisashi
    Ying, Huang
    Sato, Yorifumi
    Miyazato, Paola
    Yao, Masahiro
    Nagashima, Yoji
    Furuya, Mitsuko
    Oike, Yuchi
    Kamba, Tomomi
    Laura, S. Schmidt
    Marston, Lineha W.
    Baba, Masaya
    CANCER SCIENCE, 2018, 109 : 333 - 333
  • [32] TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma
    Xu, Yongcan
    Rao, Qiu
    Xia, Qiuyuan
    Shi, Shanshan
    Shi, Qunli
    Ma, Henghui
    Lu, Zhenfeng
    Chen, Hui
    Zhou, Xiaojun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 2690 - 2699
  • [33] Clinicopathological and prognostic significance of TFE3 in papillary renal carcinoma
    Takamatsu, T.
    Kenichi, K.
    Daisuke, K.
    Fumio, K.
    Masaki, S.
    Yoshinao, O.
    Masatoshi, E.
    EUROPEAN UROLOGY, 2021, 79 : S738 - S738
  • [34] Renal Cell Carcinomas with TFE3 Gene Fusion: Report of 85 cases with TFE3 Fusion Status Confirmed by Fluorescence In Situ Hybridization (FISH)
    Akgul, Mahmut
    Cheng, Liang
    Grignon, David
    Eble, John
    Idrees, Muhammad
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 844 - 845
  • [35] Clinicopathological features and transcriptomic profiles of MED15-TFE3-rearranged renal cell carcinoma: A retrospective study of 14 cases
    He, S.
    Liu, H.
    Hu, X.
    Sun, G.
    Shen, P.
    Zeng, H.
    ANNALS OF ONCOLOGY, 2024, 35
  • [36] Renal Cell Carcinomas with TFE3 Gene Fusion: Report of 85 cases with TFE3 Fusion Status Confirmed by Fluorescence In Situ Hybridization (FISH)
    Akgul, Mahmut
    Cheng, Liang
    Grignon, David
    Eble, John
    Idrees, Muhammad
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 844 - 845
  • [37] TFE3 is related with PI3K/Akt pathway in renal cell carcinoma
    Lee, H. J.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S184 - S185
  • [38] TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis
    Lee, Hyun Jung
    Shin, Dong Hoon
    Kim, So Young
    Hwang, Chung Su
    Lee, Jung Hee
    Park, Won Young
    Choi, Kyung Un
    Kim, Jee Yeon
    Lee, Chang Hun
    Sol, Mee Young
    Rha, Seo Hee
    Park, Sung Woo
    HISTOPATHOLOGY, 2018, 73 (05) : 758 - 766
  • [39] Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report
    Paksoy, Nail
    Erdem, Selcuk
    Karaca, Mert
    Ak, Naziye
    Pehlivan, Metin
    Yirgin, Inci K.
    Ozluk, Yasemin
    Ekiz, Feza
    Tural, Deniz
    Ekenel, Meltem
    Ozcan, Faruk
    Basaran, Mert
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 215 - 221
  • [40] TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
    Aldera, Alessandro Pietro
    Ramburan, Amsha
    John, Jeff
    UROLOGY CASE REPORTS, 2022, 42
12345